Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 350 of 5804
-
Fluorescent dye guides Stomach-Sparing surgery for early cancer
Disease control ENROLLING_BY_INVITATIONGastric cancer is a common malignant tumour worldwide, and in China, the incidence and mortality rates of gastric cancer remain high. Standardised surgical treatment is effective, but the normal structure of the stomach undergoes irreversible changes, leading to a series of adver…
Phase: NA • Sponsor: wangdongsheng • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New radiation treatment shows promise for skin cancer in immunocompromised patients
Disease control Recruiting nowThis is a multi-center clinical study enrolling up to 28 participants. The primary objectives are to determine the objective response rate (ORR) established by the confirmed best overall response (BOR) following intratumoral administration of DaRT - Diffusing Alpha-Emitters Radia…
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Blood sugar control may boost chemo survival in pancreatic cancer patients
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy of anti-diabetic treatment on improving the overall survival for metastatic pancreatic cancer patients complicated by diabetes receiving gemcitabine and nab-paclitaxel chemotherapy.
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Robot surgery vs. standard care for brain stem bleeding: a major trial begins
Disease control Not yet recruitingThis clinical study is a high-level evidence-based medical research project designed to compare the efficacy differences between stereotactic aspiration and conservative treatment in patients with brainstem hemorrhage. Brainstem hemorrhage is a life-threatening condition with ext…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug cocktail aims to reverse fatty liver damage in diabetics
Disease control Recruiting nowThis trial aims to evaluate the efficacy and safety of chiglitazar as a combination therapy for patients with MASH and T2DM.
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could blood filtering ease long COVID? new trial aims to find out
Disease control Recruiting nowSome people continue to have serious symptoms long after COVID-19, such as extreme fatigue and feeling worse after activity. In some patients, this may happen because the immune system is attacking the body by mistake. This study will test a treatment called immunoadsorption, wh…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Drug duo aims to turn inoperable lung cancer into surgical candidates
Disease control Recruiting nowThis study is a prospective, single-arm, exploratory clinical research aimed at evaluating the efficacy and safety of lucetamab in combination with leucovorin in the conversion therapy of locally advanced potentially resectable EGFR mutation-positive non-small cell lung cancer, p…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug aims to shield kidneys and heart in diabetic patients
Disease control Not yet recruitingTo assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD.
Phase: NA • Sponsor: College of Physicians and Surgeons Pakistan • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New cocktail aims to outsmart Drug-Resistant liver cancer
Disease control Not yet recruitingBackground: Hepatocellular carcinoma (HCC) stands as a formidable global health challenge. It ranks as the sixth most common malignant solid tumor worldwide and the third leading cause of cancer-related mortality. The disease is characterized by its insidious onset, rapid progres…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Stroke study could change how doctors handle high blood pressure in emergency clot treatment
Disease control Not yet recruitingElevated blood pressure (BP) is nearly universal in acute ischemic stroke (AIS) and critically influences eligibility for intravenous thrombolysis; however, current guidelines-requiring BP reduction to below 185/110 mmHg before treatment-lack robust evidence and may delay reperfu…
Phase: NA • Sponsor: Bo Wu • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Engineered immune cells take on stomach cancer in new trial
Disease control Not yet recruitingThis is a single-arm, open-label clinical study evaluating the safety and preliminary efficacy of a novel hypoxia-inducible, bispecific CD73/AXL-targeting CAR-T cell product, XW-LTH-03, in patients with stage IV gastric cancer (GC). The primary objective is to assess the safety a…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a common anesthetic keep lung cancer from returning?
Disease control Not yet recruitingThe goal of this clinical trial is to explore if perioperative lidocaine infusion decreases disease reoccurrence and metastasis risk in non-small cell lung cancer patients. Participants will be randomly assigned (1:1) to the lidocaine or placebo group. The intervention initiates…
Phase: NA • Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental vaccine aims to boost immune attack on glioblastoma
Disease control Not yet recruitingGlioblastomas (GBM) are the most frequent brain tumors and one of the most lethal adult cancers despite maximal multimodal therapy. Despite maximal safe resection followed by radiotherapy and temozolomide (TMZ) ± tumor-treating fields, median overall survival for newly diagnosed …
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo targets lung cancer brain tumors in 60-patient trial
Disease control Not yet recruitingThis multicenter study evaluates the efficacy and safety of furmonertinib 160mg versus furmonertinib 80mg plus chemotherapy (carboplatin + pemetrexed) as first-line treatment for EGFR-mutated NSCLC patients with brain metastases. It aims to determine which approach is more effect…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Armored cells take on tough lymphoma in early trial
Disease control Recruiting nowThe purpose of this study is to investigate the safety and tolerability of anti-PD1 armored CD19 CAR-T Cells in adult subjects with relapsed or refractory diffuse large B-cell lymphoma.
Phase: PHASE1 • Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New stent procedure offers hope for High-Risk aortic tear patients
Disease control Recruiting nowThis study is a single-arm, open-label, multi-center clinical trial evaluating the safety and efficacy of endovascular treatment for retrograde dissection involving the ascending aorta that is not suitable for open surgery. The aim is to assess the short-term (30 days) and medium…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Freeze-Heat treatment may replace scalpel for some breast cancers
Disease control Recruiting nowBreast-conserving surgery has been widely used in clinical practice, but surgical incisions still impact postoperative patient satisfaction with breast appearance. The development of tumor ablation technologies has introduced new possibilities for breast cancer surgical treatment…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo aims to treat brain metastases while protecting memory
Disease control Recruiting nowThis is a single-arm, multicenter, open-label, phase Ⅱ exploratory clinical study, which plans to enroll 74 treatment-naive patients with EGFR-sensitive mutations (exon 19 deletion, exon 21 L858R mutation) and symptomatic brain metastases from non-small cell lung cancer (NSCLC). …
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Brain aneurysm repair: Stent-Assisted coiling put to the test
Disease control Recruiting nowTo determine the perioperative safety and efficacy of stent-assisted coil embolization of intracranial aneurysms in the acute phase. Intravenous antiplatelet drugs that are clinically easy to administer, have good reproducibility and good controllability are used.The program focu…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for advanced bowel cancer: experimental drug combo enters major trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemotherapy in participants with previously untreated, unresectable, or metastatic colorectal cancer
Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC